Cargando…
Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy()()
Androgenetic alopecia (AGA) is a common clinical condition, affecting over 200 million people globally each year. For decades, Minoxidil (Mi) tincture has been the primary treatment for this disease, but its low utilization rate and significant side effects necessitate new therapeutic strategies. Ni...
Autores principales: | Xing, Hui, Peng, Huanqi, Yang, Yuhui, Lv, Kai, Zhou, Shihao, Pan, Xiangjun, Wang, Jianjin, Hu, Yunfeng, Li, Guowei, Ma, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582348/ https://www.ncbi.nlm.nih.gov/pubmed/37859688 http://dx.doi.org/10.1016/j.bioactmat.2023.09.021 |
Ejemplares similares
-
New Target for Minoxidil in the Treatment of Androgenetic Alopecia
por: Shen, Yuqing, et al.
Publicado: (2023) -
Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia
por: Shadi, Zari
Publicado: (2023) -
Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia
por: Ragi, Sara D., et al.
Publicado: (2023) -
Scalp vascularization as a marker of topical minoxidil treatment efficacy in patients with androgenetic alopecia
por: Kozicka, Karolina, et al.
Publicado: (2021) -
Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia
por: Jeong, Woo Yeup, et al.
Publicado: (2019)